Information Technology
Global Mass Spectrometry Market to Reach USD 9.62 Billion by 2030 Amid Rising Pharmaceutical R&D, Environmental Testing, and AI-Powered Advancements: MarkNtel Advisors
The Mass Spectrometry Global Market is seeing dynamic activity from top mass spectrometry manufacturers/companies aiming to expand their market share. Key players like Thermo Fisher Scientific Inc., Agilent Technologies Inc., and Waters Corporation are leading the way, alongside Danaher Corporation, Bruker Corporation, and Shimadzu Corporation. Companies such as PerkinElmer Inc., JEOL Ltd., LECO Corporation, and Advion Inc. are actively pursuing mergers, collaborations, and acquisitions to enhance their competitive advantage.
Their focus on innovation, research and development, and diverse product portfolios positions them for sustained growth in an evolving industry. With a commitment to improving operational efficiency and addressing market demands, these firms are shaping the future of analytical instruments and driving revenue growth in the mass spectrometry sector.
Mass spectrometry has become a cornerstone technology for high-precision analytical testing, enabling industries to identify, quantify, and characterize chemical compounds with unmatched accuracy. The surge in adoption is driven by multiple high-growth sectors:
Based on mass spectrometry product type segment market is led by instruments, particularly hybrid mass spectrometers. These devices combine different mass analyzers, enhancing sensitivity and accuracy. Their ability to generate complex data quickly drives widespread adoption and necessitates software for data management.
The OMICS research segment is projected to grow notably in mass spectrometry. Its applications in diagnostics and biomarker identification, particularly in biopharma and genomics, are driving advancement, especially in diabetes and newborn screening.
The pharmaceutical sector is expected to see the fastest growth in mass spectrometry. Increased regulations in drug manufacturing and advancements in QC processes are pushing pharmaceutical companies to adopt mass spectrometers, solidifying their dominant position in the market.
North America leads the mass spectrometry market, holding a 38% share, thanks to its robust pharmaceutical and biotech sectors. Key companies like Pfizer, Johnson & Johnson, and Merck in the U.S., along with Canada's Apotex, drive innovation in drug discovery and testing. Significant government and private funding for R&D, such as grants from the National Institutes of Health and the Canada Foundation for Innovation, further bolster the region's market position. These investments highlight North America's prominent role in advancing mass spectrometry technology.
The market was USD 6.33 billion in 2024 and is projected to reach USD 9.62 billion by 2030 at a 7.2% CAGR, driven by pharma R&D, food safety testing, and environmental monitoring.
Costs range from USD 75,000 to USD 500,000 . GC-MS averages USD 50 ,000–115,000, while advanced hybrid and high-resolution systems exceed USD 400,000 .
, . introduced the InfinityLab Pro iQ Series, which includes the Pro iQ and Pro iQ Plus LC–MS detectors designed for quicker, smarter, and more automated laboratory processes. Alongside, they upgraded the 8850 GC system for compatibility with mass spectrometry. These innovations are smaller, faster, and more eco-friendly, earning certification from My Green Lab for sustainability.
Integration of artificial intelligence with MS devices is one of the key trends shaping the growth of the Mass Spectrometry Market.
Challenges include high upfront costs, ongoing consumable expenses, complex operation, infrastructure needs, and a global shortage of skilled analysts.
Pharma companies rely on MS for drug discovery, nitrosamine impurity profiling, biologics QC, biomarker validation, and regulatory compliance testing.
Yes. Hospitals use MS for toxicology, newborn screening, infectious disease biomarker testing, therapeutic drug monitoring, and personalized medicine diagnostics.
Key players include Agilent, Thermo Fisher , Danaher (SCIEX), Waters, Bruker, Shimadzu, PerkinElmer, JEOL, and Hitachi High-Tech.
They require precision engineering, high-tech detectors, proprietary software, costly consumables, and rigorous calibration standards, which increase price.
Growth will be strongest in pharma & biotech, food & beverage safety, environmental testing, clinical diagnostics, energy/petrochemicals, and forensic sciences.
MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.
We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific , Europe , the Middle East & Africa , etc., and many countries across the regional scale, namely, the US, India , the Netherlands , Saudi Arabia , the UAE, Brazil , and several others.
Logo: https://mma.prnewswire.com/media/2687299/MarkNtel_Advisors_Logo.jpg
Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301,
India
Contact No: +91 8719999009
Email: sales@marknteladvisors.com
https://www.marknteladvisors.com
https://www.marknteladvisors.com/press-release/mass-spectrometry-market-size
View original content:https://www.prnewswire.co.uk/news-releases/global-mass-spectrometry-market-to-reach-usd-9-62-billion-by-2030-amid-rising-pharmaceutical-rd-environmental-testing-and-ai-powered-advancements-markntel-advisors-302534760.html